WHO ICTRP trial
A clinical trial to study the preventive effect of zoledronic acid therapy on…
CTRI/2014/09/004943 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2014/09/004943 |
|---|---|
| Public title | A clinical trial to study the preventive effect of zoledronic acid therapy on drug induced bone loss in breast cancer |
| Scientific title | Effect of zoledronic acid therapy on aromatase inhibitor induced bone loss in postmenopausal Hormone Responsive Early Breast Cancer |
| Primary sponsor | Dr Ved Prakash |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- postmenopausal hormone receptor positive early breast cancer (stage I-IIIA) patients, who had had primary surgery, did not have recurrent or metastatic disease treated with aromatase inhibitor |
| Interventions | Intervention1: Zoledronic acid: 5 mg i.v. stat once Control Intervention1: Not Applicable: Not applicable |
| Registration date | Jan 9, 2014 |
| Target size | 20 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: